Metagenomi Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-77.27	-68.26	-43.59	-21.44
Depreciation & Amortization	4.64	4.21	1.73	0.39
Asset Writedown & Restructuring Costs	0.03	0.02	0.28	-
Loss (Gain) From Sale of Investments	-10.41	-11.34	-1.22	-2.56
Stock-Based Compensation	11.45	6.92	1.96	0.38
Other Operating Activities	3.66	3.47	1.08	1.24
Change in Accounts Receivable	-2.08	-1.18	-1.27	-
Change in Accounts Payable	1.87	-0.08	0.72	0.7
Change in Unearned Revenue	-32.87	-30.3	65.66	44.23
Change in Income Taxes	-0.21	1.73	1.54	-
Change in Other Net Operating Assets	0.93	3.4	2.84	1.33
Operating Cash Flow	-100.26	-91.41	29.72	24.26
Operating Cash Flow Growth	-	-	22.54%	-
Capital Expenditures	-8.06	-9.81	-13.98	-2.9
Investment in Securities	31.13	55.55	-108.22	-71.41
Investing Cash Flow	23.07	45.73	-122.2	-74.32
Long-Term Debt Issued	-	-	-	29.97
Net Debt Issued (Repaid)	-	-	-	29.97
Issuance of Common Stock	86.54	-	-	-
Other Financing Activities	-3.28	-3.28	-	-
Financing Cash Flow	83.25	1.01	239.59	39.92
Net Cash Flow	6.06	-44.66	147.12	-10.14
Free Cash Flow	-108.33	-101.22	15.75	21.35
Free Cash Flow Growth	-	-	-26.26%	-
Free Cash Flow Margin	-229.22%	-226.17%	91.55%	8787.65%
Free Cash Flow Per Share	-13.82	-29.73	4.63	3.75
Cash Interest Paid	6.56	6.56	2.16	1.45
Levered Free Cash Flow	-	-31.65	-19.71	-
Unlevered Free Cash Flow	-	-31.65	-19.65	-
Change in Net Working Capital	-	-16.09	-18.53	-

Source: S&P Capital IQ. Standard template.